DNA damage marker phosphorylated histone H2AX is a potential predictive marker for progression of epithelial dysplasia of the oral cavity Aims: To evaluate the relationships between immunohistochemical markers related to cellular senescence, cell proliferation and histological grade of epithelial dysplasia (OD) of the oral cavity. In addition, the predictive value of these markers for progression of OD was assessed. Methods and results: Retrospective immunohistochemical analyses were performed on 86 formalinfixed paraffin-embedded specimens of OD and oral squamous cell carcinoma (OSCC) for Ki67, phosphorylated histone H2AX (cH2AX), p53, p16, trimethyl-histone H3 (Lys9) (H3K9me3) and cyclin D1 (CycD1). Three separate areas representing the highest severity of OD on each slide were annotated digitally by two independent pathologists. Mean automated histoscores of the selected markers were generated and compared to that of age-matched healthy controls (n = 24). Follow-up data of OD were retrieved and anonymized by a clinical team member and linked using unique participant identifiers. The median follow-up was 10.9 years (interquartile range: 10.1-11.5). Ki67 (P < 0.0001), cH2AX (P = 0.03) and p53 (P = 0.04) were increased significantly with higher histological grade of OD. cH2AX (P = 0.03), but not histological grade of OD (P = 0.73), was associated prospectively with disease progression. Using the median histoscore for cH2AX (median histoscore = 17) as a cut-off, histoscore ≥17 was associated with an increased risk of disease progression [hazard ratio (HR) = 3.15, 95% confidence interval (CI): 1.41-7.39, P = 0.0064]. Conclusions: Although proliferation marker Ki67, DNA damage/checkpoint markers cH2AX and p53 were increased in higher grade of OD, only cH2AX was predictive of disease progression. These observations may reflect the role of DNA replicative stress in the transformation from OD to OSCC. Larger studies should evaluate whether cH2AX can be used as a predictive marker of OD.
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Introduction
Although oral cancer accounts for only 3% of all cancer cases, its worldwide incidence has increased in recent years. 1 This increase has been associated with human papillomavirus infection, particularly the high-risk HPV-16 subtype, in cancers of the oropharynx. 2 Oral epithelial dysplasia (OD) is a known premalignant condition associated with oral squamous cell carcinoma (OSCC). Clinically, OD lesions appear as white or red patches (leucoplakia and erythroplakia, respectively) occurring anywhere on the mucosal surfaces of the mouth.
Although histological assessment is the gold standard for diagnosis and the grade of OD is a key risk factor of malignant transformation, its assessment is subjective with substantial interobserver variability. 3, 4 Moreover, the majority of OD lesions do not progress to cancer: reported progression rates ranged between 6 and 36%. 5, 6 Although significant efforts have been made to improve the predictive value of histological grading, e.g. by combining DNA ploidy analysis with OD grading, 7 accurate positive predictive markers of progression do not exist. 8, 9 The mainstay treatment for OD remains regular surveillance and surgical resection 10 and patients with recurrence (10-20% of those with OD) may require multiple operations in an anatomically confined and complex region with a significant impact on quality of life. Hence, improved understanding of the molecular mechanisms underlying the progression from OD to OSCC could help to stratify risks of patients with OD and streamline their follow-up, with the potential to identify malignant transformation early, while minimizing morbidity from active surveillance and repeat resections. 11 Key proteins in cell cycle and proliferation control have been evaluated as candidate biomarkers to predict progression in OD, with limited success. 12 Senescence is an irreversible form of growth arrest and, once it is established, cells are unable to express genes required for proliferation even when exposed to mitogenic growth factors. Hence, senescence is a potent mechanism of tumour suppression, associated with human and mouse benign neoplastic lesions. 11, 13 Senescent cells continue to remain metabolically active with characteristic large flattened morphology (at least in vitro), and also display characteristic changes in gene expression. 14 At the molecular level, replicative senescence of human cells is triggered by telomere attrition, which is registered by the cell as DNA damage and results in the activation of the tumour suppressor gene TP53. During replicative senescence, the CDK inhibitor p16INK4a accumulates in the cell, inhibiting the CDK-mediated phosphorylation of pRB and contributing to cell cycle arrest. These two pathways are essential for senescence activation in human cells, and alterations of these pathways have been reported in large cohorts of OSCC and OD. 15 In addition, senescence can be triggered by the presence of an activated oncogene in an otherwise normal cell. 13 This study aimed to evaluate whether the expression of markers related to cellular senescence was altered in OD, compared to normal oral epithelium. In addition, the predictive potential of these markers was explored.
Materials and methods

E T H I C A L A P P R O V A L
This study was approved by the local ethics committee of the West of Scotland on 3 December 2010 (REC reference number: 10/S0704/56).
Pathological archival specimens Anonymized surplus formalin fixed and paraffin embedded (FFPE) specimens of OD and OSCC were identified retrospectively and retrieved from the NHS Greater Glasgow and Clyde Biorepository by a pathologist (D.M.). Follow-up data of OD were retrieved and anonymized by a member of the clinical team (N.S.) using unique participant identifiers.
Age-matched normal control samples
Age-matched healthy volunteers were identified at the head and neck surgical outpatient clinic of the Queen Elizabeth University Hospital (Glasgow, UK) by a consultant surgeon (J.D.M.), who provided routine care of the volunteers. Study participation was voluntary and written informed consent was obtained from each volunteer.
Biopsy procedure for healthy age-matched volunteers A single 4-mm disc of normal oral mucosa was obtained from each volunteer using a punch biopsy device after infiltration of a local anaesthetic. Standard antiseptic technique was followed. All biopsy specimens were fixed in neutral buffered formalin and embedded in paraffin before immunohistochemical staining. and M7023 (negative control; Sigma-Aldrich, Poole, UK, polyclonal) at 1 in 9000. Apart from p16 and CycD1 staining, all staining was performed after heat-induced epitope retrieval in citrate buffer at pH6. For p16 and CycD1 staining, antigen retrieval was performed in Tris-ethylenediamine tetraacetic acid (EDTA) at pH 9 and EDTA pH 8, respectively.
Immunohistochemistry
Interpretation of immunohistochemical assays
Stained slides were digitized (Hamamatsu NanoZoomer NDP, Hamamatsu Photonics, Welwyn Garden City, UK), reviewed and analysed using Slidepath Digital Image Hub V4.0.7 (Leica Microsystems, Milton Keynes, UK).
Histological grade of OD and qualitative assessments of the histology slides were performed by two collaborating pathologists (K.H. and C.E.M.), who were blinded to the histological grade of the original diagnostic report at the time of their assessments. As discrete areas of OD often develop within a background of normal tissue, three separate areas representing the highest severity of OD on each slide were annotated digitally based on haematoxylin and eosinstained specimen slides before the assessment of other immunohistochemical markers. For specimens from normal healthy controls, three random areas of normal epithelium were annotated. Automated histoscores (0 9 % negative cells + 1 9 % weakly stained cells + 2 9 % moderately stained cells + 3 9 % strongly stained cells) of the annotated areas were then generated by digital image analysis. Mean values of the histoscores generated from the three separate areas of each slides were used for statistical analysis of the immunohistochemical markers assessed. Each histoscore has a range of possible scores between 0 and 300. The algorithms used were unable to generate histoscores for <5% of samples.
Human papillomavirus (HPV) status
The HPV status of p16-positive specimens was evaluated by HPV 16/18 polymerase chain reaction (PCR) at the Queen Elizabeth University Hospital (Glasgow, UK), according to established protocol.
S T A T I S T I C A L A N A L Y S I S
Statistical tests were performed using Prism version 6 (GraphPad Software, San Diego, CA, USA). Differences between groups were analysed using KruskalWallis and Mann-Whitney U-tests, as the data were not distributed normally. Significance was considered with a P-value below 0.05. The level of statistical significance is indicated using asterisks (*P < 0.05 and ****P < 0.0001). When appropriate, data were presented as median and interquartile range (IQR). Survival analysis was performed using the log-rank test; hazard ratio (HR) and 95% confidence intervals (95% CI) were presented in addition to P-value.
Results
T H E R E L A T I O N S H I P S B E T W E E N G R A D E O F D I S E A S E A N D B I O M A R K E R S A S S E S S E D
For the archival specimens (n = 86), only age and histological grade at diagnosis were available. The median age of diagnosis was 64.6 years old [interquartile range (IQR): 53.9-71.5]. Twenty-four (27.9%) of these archival specimens had mild OD, 17 (19.8%) had moderate OD, 32 (37.2%) had severe OD and 13 (15.1%) had OSCC. Automated histoscores of the assessed immunohistochemical markers were compared by grade of disease, compared to 24 normal age-matched controls (Table 1, Figure 1 and Supporting information, Figure S1 ). With respect to p16 expression, seven of the 32 severe OD specimens (21.9%) expressed a high level of p16. Given the known link between HPV status and p16, their HPV status was evaluated. Five were HPV-positive (71.4%, all HPV-16-positive), one was negative (14.3%) and one had too little remaining DNA for assessment (14.3%). More significantly, the expression of Ki67 (P < 0.0001), cH2AX (P = 0.03) and p53 (P = 0.04) was increased with significantly higher histological grade of OD. The expression of these biomarkers plateaued or reversed in OSCC.
T H E R E L A T I O N S H I P S B E T W E E N B I O M A R K E R S A S S E S S E D A N D D I S E A S E P R O G R E S S I O N
The median follow-up was 10.9 years (IQR: 10.1-11.5). Of the 73 patients with OD, 18 improved and were discharged from follow-up (24.7%), four progressed to higher grade of dysplasia (5.6%) and 19 progressed to develop malignancies (26.0%). For the 23 patients with disease progression, the median time to progression was 6.0 years (IQR: 4-6.9). There was no difference in the rate of progression by grade of dysplasia (Supporting information, Figure S2 , P = 0.73).
The relationships between assessed biomarkers and disease progression in patients with OD were evaluated ( Table 2 ). Two of the seven patients with a high level of p16 (28.6%) progressed to develop OSCC, only one of whom had confirmed HPV infection. Most interestingly, increased cH2AX was associated with disease progression (Table 2 , P = 0.03). Using the median histoscore for cH2AX (median histoscore = 17) as a cutoff, histoscore ≥17 was associated with an increased risk of disease progression (Figure 2 ; HR = 3.15, 95% CI: 1.41-7.39, P = 0.0064).
Discussion
M A I N F I N D I N G S , S T R E N G T H S A N D L I M I T A T I O N S
Higher histological grades of OD were associated significantly with increased Ki67, cH2AX and p53, and subsequently plateaued or reversed in patients with malignancy, similar to changes observed in patients with Barrett's oesophagus. 16 Moreover, cH2AX, the predictive value of which has not been thoroughly evaluated, 6 was associated with disease progression. Although p16 expression is an established marker of senescence, infection with HPV up-regulates expression of non-functional p16 due to the loss of pRB function, which is unlikely to be associated with senescence. Indeed, in patients with severe OD, the majority of specimens with high p16 expression had confirmed HPV infection. Consistent with previous reports that only a small proportion of patients with OSCC (<5%) were infected with HPV 17 and that p16 was a poor predictive marker of OD, 8, 18 p16 was not associated with increasing histological grade of OD nor progression in this cohort. Other novel senescence markers assessed in this study did not show significant changes in expression by grade of OD or progression status.
This study is one of the few studies reported to date that included a normal age-matched control group. 8, 19 This highlights the feasibility of establishing a cohort of normal healthy controls, which is important for the development of clinically relevant biomarkers. 20 In addition, this study also procured sufficiently long follow-up, and the rate of progression to malignancy was similar to that in previously reported studies (26%). 5, 6 However, the number of participants included in this exploratory study was small. It had limited power to detect small changes in the expression of the biomarkers assessed. Moreover, multiple comparisons could increase the probability of type I errors. Therefore, larger studies would be required to validate the associations observed.
R E C O M M E N D A T I O N S F O R F U T U R E S T U D I E S
The expression of proliferation markers Ki67, DNA damage/checkpoint markers cH2AX and p53 was significantly higher with increasing grades of OD, which may aid in the determination of histological grade of OD. The significance of the observed patterns of expression of Ki67, cH2AX and p53 in OSCC is unclear. Including normal controls in future biomarker studies will help to confirm the patterns observed.
While grade of dysplasia did not predict progression in this cohort of patients, cH2AX overexpression was associated significantly with disease progression, with p53 showing a similar trend. It was proposed previously that DNA replication stress, consistent with cH2AX overexpression observed, may promote genomic instability that may encourage progression from OD to OSCC. 21 Future studies could evaluate further whether the combination of these two common immunohistochemical markers, cH2AX and p53, may predict more accurately the progression of OD.
Conclusion
Although proliferation markers Ki67, DNA damage/ checkpoint markers cH2AX and p53 were increased in higher grades of OD, only cH2AX was associated with disease progression, which may indicate the potential of DNA replicative stress in the transformation from OD to OSCC. Larger studies could evaluate whether cH2AX could be used as a predictive marker of OD.
